H1B Salary Data

Home › Employers › Simcere Zaiming Inc

Simcere Zaiming Inc: H-1B salaries and sponsorship

Simcere Zaiming Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $72,800.

Applications (LCAs)4
Certified3
Employer addressCambridge, MA
H-1B dependent employerNo
Median offered salary$72,800
Middle half of salaries$70,400–$101,400
10th–90th percentile$68,960–$118,560

Does Simcere Zaiming Inc sponsor H-1B visas?

Simcere Zaiming Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 14, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Scientist I2$130,000
Research Associate1$72,800
Clinical Trial Coordinator1$68,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$130,000
FY20241$72,800
FY20261$68,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Clinical Trial Coordinator$68,000
Level I
Cambridge, MAApr 14, 2026Oct 1, 2026Certified
Research Associate$72,800
Level I
Cambridge, MANov 1, 2023Nov 15, 2023Certified
Senior Scientist I$130,000
Level III
Cambridge, MAJun 8, 2023Jul 15, 2023Certified
Senior Scientist I$130,000
Level III
Cambridge, MAJun 6, 2023Jul 15, 2023Denied

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).